Literature DB >> 6342764

Cerebrospinal fluid GABA measurements: basic and clinical considerations.

B V Manyam, T A Hare.   

Abstract

The valid measurement of GABA concentration in the CSF for studying in vivo alterations of central nervous system GABAergic activity requires that consideration be given to several factors that affect GABA concentration. These factors include in vivo variables such as the caudocranial concentration gradient in CSF, age, sex, precursor intake, medications, and physical activity, as well as in vitro alterations that can occur during collection, storage, preparation of sample, and analysis. The influence of these factors can be minimized with proper methodology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342764     DOI: 10.1097/00002826-198303000-00003

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  5 in total

Review 1.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid.

Authors:  Jurjen J Luykx; Christiaan H Vinkers; Steven C Bakker; Wouter F Visser; Loes van Boxmeer; Eric Strengman; Kristel R van Eijk; Judith A Lens; Paul Borgdorff; Peter Keijzers; Teus H Kappen; Eric P A van Dongen; Peter Bruins; Nanda M Verhoeven; Tom J de Koning; René S Kahn; Roel A Ophoff
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

3.  CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls.

Authors:  C Nordin; I Sjödin
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

4.  Sex differences in the sensitivity of CBA mice to convulsions induced by GABA antagonists are age-dependent.

Authors:  H Manev; D Pericić; S Anić-Stojiljković
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Elizabeth Stuller; David Miller; John Giordano; Siobhan Morse; Lee McCormick; William B Downs; Roger L Waite; Debmalya Barh; Dennis Neal; Eric R Braverman; Raquel Lohmann; Joan Borsten; Mary Hauser; David Han; Yijun Liu; Manya Helman; Thomas Simpatico
Journal:  J Addict Res Ther       Date:  2012-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.